Osaka, Japan

Iwao Yamanaka

This inventor holds 3 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astra Aktiebolag. Active years: 1993-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iwao Yamanaka. Retrieved from https://idiyas.com/inventor/iwao-yamanaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Iwao Yamanaka: A Pioneer in Pharmaceutical Innovations

Introduction

Iwao Yamanaka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work has focused on developing innovative solutions that address critical health issues.

Latest Patents

Yamanaka's latest patents include an injection and injection kit containing omeprazole and its analogs. He has also developed a pharmaceutical solution containing FK-506, which is known for its immunosuppressive activity. These inventions highlight his commitment to advancing medical treatments and improving patient care.

Career Highlights

Throughout his career, Yamanaka has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astra Aktiebolag. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Yamanaka has collaborated with esteemed colleagues such as Shigeo Nakanishi and Tetsuo Tominaga. These partnerships have fostered a creative environment that has led to the development of innovative pharmaceutical solutions.

Conclusion

Iwao Yamanaka's contributions to the pharmaceutical field through his patents and collaborations demonstrate his dedication to innovation and improving healthcare. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…